Invention Grant
- Patent Title: Oxazine compound and application thereof
-
Application No.: US17053042Application Date: 2019-04-22
-
Publication No.: US11639360B2Publication Date: 2023-05-02
- Inventor: Jiangli Fan , Qichao Yao , Haidong Li , Yana Bian , Mingle Li , Jingyun Wang , Xiaojun Peng
- Applicant: DALIAN UNIVERSITY OF TECHNOLOGY , DALIAN CHROMAS BIOSCIENCE CO., LTD
- Applicant Address: CN Liaoning; CN Liaoning
- Assignee: DALIAN UNIVERSITY OF TECHNOLOGY,DALIAN CHROMAS BIOSCIENCE CO., LTD
- Current Assignee: DALIAN UNIVERSITY OF TECHNOLOGY,DALIAN CHROMAS BIOSCIENCE CO., LTD
- Current Assignee Address: CN Liaoning; CN Liaoning
- Agency: Novick, Kim & Lee, PLLC
- Agent Allen Xue
- Priority: CN201810420618.1 20180504
- International Application: PCT/CN2019/083615 WO 20190422
- International Announcement: WO2019/210786 WO 20191107
- Main IPC: C07D517/16
- IPC: C07D517/16 ; A61P35/00 ; A61K9/14 ; A61K41/00 ; C07D513/16 ; C09K11/06 ; G01N21/64

Abstract:
Disclosed are an oxazine compound and an application thereof. The oxazine compound has a structure of a general formula F. The oxazine compound described in the disclosure is a photo/acoustic dynamic active organic molecule with near-infrared absorption-emission function as well as photosensitivity and acoustic sensitivity. Maximum absorption and emission wavelengths of the compound are both greater than 660 nanometers, and a triplet-state conversion rate of the compound is high; and under illumination or ultrasound, the compound can produce reactive oxygen species with high efficiency, which has a good killing effect on cancer cells and cancer tissues, and almost has no toxic or side effects on normal tissues while achieving photo/acoustic dynamic therapy on tumors.
Public/Granted literature
- US20210188875A1 OXAZINE COMPOUND AND APPLICATION THEREOF Public/Granted day:2021-06-24
Information query